+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Aneurysmal Subarachnoid Hemorrhage Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768297
  • Report
  • April 2019
  • Region: Global
  • 79 pages
  • VPA Research
UP TO OFF
until Oct 31st 2021

FEATURED COMPANIES

  • Actelion Ltd
  • Edge Therapeutics Inc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Medpace Investors LLC
  • Nestle SA
  • MORE
The global clinical trial report- “2019 Aneurysmal Subarachnoid Hemorrhage Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Aneurysmal Subarachnoid Hemorrhage. It presents in-depth analysis of Aneurysmal Subarachnoid Hemorrhage clinical trials across markets and companies. The research work is for providing complete understanding into trends in Aneurysmal Subarachnoid Hemorrhage.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Aneurysmal Subarachnoid Hemorrhage clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Aneurysmal Subarachnoid Hemorrhage

The research work is prepared through extensive and continuous research on Aneurysmal Subarachnoid Hemorrhage trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Aneurysmal Subarachnoid Hemorrhage patients are identified
  • The report includes panorama of Aneurysmal Subarachnoid Hemorrhage clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Aneurysmal Subarachnoid Hemorrhage clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Actelion Ltd
  • Edge Therapeutics Inc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Medpace Investors LLC
  • Nestle SA
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Aneurysmal Subarachnoid Hemorrhage Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Aneurysmal Subarachnoid Hemorrhage Clinical Trials by Region
2.2.2 Average Enrollment of Aneurysmal Subarachnoid Hemorrhage Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Aneurysmal Subarachnoid Hemorrhage Treatment, 2019

3. Region wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials
3.1 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Clinical Trials by Country
3.2 Europe Aneurysmal Subarachnoid Hemorrhage Clinical Trials by Country
3.3 North America Aneurysmal Subarachnoid Hemorrhage Clinical Trials by Country
3.4 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Clinical Trials by Country
3.5 South and Central America Aneurysmal Subarachnoid Hemorrhage Clinical Trials by Country

4. Aneurysmal Subarachnoid Hemorrhage Clinical Trial Trends
4.1 Start Year wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials
4.2 Phase wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials
4.3 Trial Status wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials
4.4 Trial Type wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials

5. Aneurysmal Subarachnoid Hemorrhage Average Enrollment Trends
5.1 Average Enrollment in Aneurysmal Subarachnoid Hemorrhage Trials by Year
5.2 Average Enrollment in Aneurysmal Subarachnoid Hemorrhage Trials by Phase
5.3 Average Enrollment in Aneurysmal Subarachnoid Hemorrhage Trials by Status
5.4 Average Enrollment in Aneurysmal Subarachnoid Hemorrhage Trials by Type of Trial

6. Companies Participating in Aneurysmal Subarachnoid Hemorrhage Clinical Trials
6.1 Aneurysmal Subarachnoid Hemorrhage Trials by Sponsor Type
6.2 Aneurysmal Subarachnoid Hemorrhage Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Aneurysmal Subarachnoid Hemorrhage Trials- Phase 1
7.2 Aneurysmal Subarachnoid Hemorrhage Trials- Phase 2
7.3 Aneurysmal Subarachnoid Hemorrhage Trials- Phase 3
7.4 Aneurysmal Subarachnoid Hemorrhage Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Aneurysmal Subarachnoid Hemorrhage Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials and Enrolment
Figure 5: Europe - Country wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials and Enrolment
Figure 7: North America - Country wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials and Enrolment
Figure 9: Aneurysmal Subarachnoid Hemorrhage Clinical Trials by Phase
Figure 10: Aneurysmal Subarachnoid Hemorrhage Clinical Trials by Trial Status
Figure 11: Aneurysmal Subarachnoid Hemorrhage Clinical Trials by Type
Figure 12: Aneurysmal Subarachnoid Hemorrhage Clinical Trials by Sponsor Type
Figure 13: Aneurysmal Subarachnoid Hemorrhage Clinical Trials by Leading Sponsors
Figure 14: Aneurysmal Subarachnoid Hemorrhage Average Enrollment by Phase
Figure 15: Aneurysmal Subarachnoid Hemorrhage Average Enrollment by Trial Status
Figure 16: Aneurysmal Subarachnoid Hemorrhage Average Enrollment by Type
Figure 17: Aneurysmal Subarachnoid Hemorrhage- Average Enrolment by Type of Sponsors
Figure 18: Aneurysmal Subarachnoid Hemorrhage- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Aneurysmal Subarachnoid Hemorrhage Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials and Enrolment
Table 5: Europe - Country wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials and Enrolment
Table 7: North America - Country wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Aneurysmal Subarachnoid Hemorrhage Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Aneurysmal Subarachnoid Hemorrhage Average Enrollment by Phase
Table 15: Aneurysmal Subarachnoid Hemorrhage Average Enrollment by Trial Status
Table 16: Aneurysmal Subarachnoid Hemorrhage Average Enrollment by Type
Table 17: Aneurysmal Subarachnoid Hemorrhage- Average Enrolment by Type of Sponsors
Table 18: Aneurysmal Subarachnoid Hemorrhage- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
  • Actelion Ltd
  • Cambridge Theranostics Ltd.
  • Edge Therapeutics Inc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Medpace Investors LLC
  • Nestle SA
  • Prolong Pharmaceuticals LLC
  • The Medicines Company
Note: Product cover images may vary from those shown
Adroll
adroll